Performance of SAGE Sage Therapeutic | -77.4% in 12m
Compare SAGE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Sage Therapeutic with its related Sector/Index XBI
Performance Duell SAGE vs XBI
| TimeFrame | SAGE | XBI |
|---|---|---|
| 1 Day | -3.57% | -0.94% |
| 1 Week | -14.6% | -2.04% |
| 1 Month | -27.7% | -2.01% |
| 3 Months | -49.8% | -3.19% |
| 6 Months | -30.4% | 31.67% |
| 12 Months | -77.4% | 1.00% |
| YTD | -47.1% | -2.32% |
| Rel. Perf. 1m | -2.77 | |
| Rel. Perf. 3m | -5.84 | |
| Rel. Perf. 6m | -6.91 | |
| Rel. Perf. 12m | -14.79 |
Is Sage Therapeutic a good stock to buy?
No, based on ValueRay Fundamental Analyses, Sage Therapeutic (NASDAQ:SAGE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -58.59 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAGE as of May 2024 is 7.96. This means that SAGE is currently overvalued and has a potential downside of -33.11% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAGE as of May 2024 is 7.96. This means that SAGE is currently overvalued and has a potential downside of -33.11% (Sold with Premium).
Is SAGE a buy, sell or hold?
- Strong Buy: 1
- Buy: 3
- Hold: 16
- Sell: 1
- Strong Sell: 0
Values above 0%: SAGE is performing better - Values below 0%: SAGE is underperforming
Compare SAGE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -16.50% | -28.97% | -49.47% | -105.37% |
| US NASDAQ 100 | QQQ | -16.14% | -28.50% | -47.69% | -114.26% |
| US Dow Jones Industrial 30 | DIA | -16.80% | -30.49% | -46.70% | -97.46% |
| German DAX 40 | DBXD | -18.71% | -31.10% | -53.20% | -94.89% |
| UK FTSE 100 | ISFU | -17.21% | -33.83% | -50.01% | -89.71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -13.80% | -33.24% | -33.63% | -66.65% |
| Hongkong Hang Seng | HSI | -17.65% | -39.41% | -35.67% | -66.74% |
| Japan Nikkei 225 | EXX7 | -12.89% | -22.99% | -43.24% | -93.12% |
| India NIFTY 50 | INDA | -12.05% | -26.03% | -45.87% | -100.78% |
| Brasil Bovespa | EWZ | -12.46% | -26.19% | -31.43% | -91.67% |
SAGE Sage Therapeutic vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -16.60% | -27.44% | -50.48% | -117.14% |
| Consumer Discretionary | XLY | -14.74% | -27.39% | -41.20% | -98.34% |
| Consumer Staples | XLP | -16.92% | -32.11% | -44.66% | -81.70% |
| Energy | XLE | -15.99% | -23.61% | -44.90% | -99.73% |
| Financial | XLF | -17.79% | -29.96% | -54.84% | -110.11% |
| Health Care | XLV | -16.59% | -29.07% | -45.05% | -87.31% |
| Industrial | XLI | -17.00% | -28.94% | -54.02% | -106.46% |
| Materials | XLB | -17.21% | -27.91% | -50.39% | -96.44% |
| Real Estate | XLRE | -16.76% | -28.25% | -42.28% | -82.07% |
| Technology | XLK | -16.11% | -28.07% | -45.35% | -113.87% |
| Utilities | XLU | -18.81% | -37.61% | -50.66% | -83.68% |
| Aerospace & Defense | XAR | -16.57% | -32.94% | -48.42% | -103.18% |
| Biotech | XBI | -12.59% | -25.65% | -62.08% | -78.39% |
| Homebuilder | XHB | -16.81% | -30.66% | -69.59% | -129.69% |
| Retail | XRT | -15.94% | -29.05% | -55.53% | -100.40% |
Does Sage Therapeutic outperform its market, is SAGE a Sector Leader?
No, over the last 12 months Sage Therapeutic (SAGE) made -77.39%, while its related Sector, the SPDR S&P Biotech (XBI) made 1.00%.
Over the last 3 months SAGE made -49.77%, while XBI made -3.19%.
No, over the last 12 months Sage Therapeutic (SAGE) made -77.39%, while its related Sector, the SPDR S&P Biotech (XBI) made 1.00%.
Over the last 3 months SAGE made -49.77%, while XBI made -3.19%.
| Period | SAGE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -27.66% | -2.01% | 1.31% |
| 3 Months | -49.77% | -3.19% | 4.24% |
| 12 Months | -77.39% | 1.00% | 27.98% |